| USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation S Ling, Q Shan, Q Zhan, Q Ye, P Liu, S Xu, X He, J Ma, J Xiang, G Jiang, ... Gut 69 (7), 1322-1334, 2020 | 136 | 2020 |
| Enhancing the efficacy and safety of doxorubicin against hepatocellular carcinoma through a modular assembly approach: the combination of polymeric prodrug design, nanoparticle … L Xu, S Xu, H Wang, J Zhang, Z Chen, L Pan, J Wang, X Wei, H Xie, ... ACS applied materials & interfaces 10 (4), 3229-3240, 2018 | 48 | 2018 |
| Self‐activated Cascade‐responsive sorafenib and USP22 shRNA Co‐delivery system for synergetic hepatocellular carcinoma therapy S Xu, S Ling, Q Shan, Q Ye, Q Zhan, G Jiang, J Zhuo, B Pan, X Wen, ... Advanced Science 8 (5), 2003042, 2021 | 40 | 2021 |
| Dimerization-induced self-assembly of a redox-responsive prodrug into nanoparticles for improved therapeutic index L Zhou, H Xie, X Chen, J Wan, S Xu, Y Han, D Chen, Y Qiao, L Zhou, ... Acta Biomaterialia 113, 464-477, 2020 | 32 | 2020 |
| Liver transplantation in patients with liver failure: twenty years of experience from China S Ling, G Jiang, Q Que, S Xu, J Chen, X Xu Liver International 42 (9), 2110-2116, 2022 | 22 | 2022 |
| Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria S Ling, T Feng, Q Zhan, X Duan, G Jiang, T Shen, Q Shan, S Xu, Q Ye, ... Annals of translational medicine 8 (4), 2020 | 19 | 2020 |
| Micropatterned poly (d, l-lactide-co-caprolactone) films entrapped with gelatin for promoting the alignment and directional migration of Schwann cells D Zhang, S Xu, S Wu, C Gao Journal of Materials Chemistry B 6 (8), 1226-1237, 2018 | 19 | 2018 |
| Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria Q Ye, S Ling, G Jiang, Q Shan, S Xu, Q Zhan, Y Wu, Y Liu, S Zheng, X Xu European Journal of Surgical Oncology 47 (10), 2533-2542, 2021 | 15 | 2021 |
| Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China QF Zhan, SB Ling, YN Deng, QN Shan, QW Ye, SJ Xu, GJ Jiang, D Lu, ... Hepatobiliary & Pancreatic Diseases International 19 (4), 349-357, 2020 | 15 | 2020 |
| E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation S Ling, Q Zhan, G Jiang, Q Shan, L Yin, R Wang, Q Que, X Wei, S Xu, ... American Journal of Transplantation 22 (10), 2323-2336, 2022 | 13 | 2022 |
| Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition) J Chen, T Shen, J Li, S Ling, Z Yang, G Wang, L Sun, Z Yang, L Zhuang, ... Chinese Medical Journal 135 (24), 2911-2913, 2022 | 11 | 2022 |
| “Sweet tooth”-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy N Ding, S Xu, S Zheng, Q Ye, L Xu, S Ling, S Xie, W Chen, Z Zhang, ... Journal of Materials Chemistry B 9 (12), 2816-2830, 2021 | 10 | 2021 |
| Salinomycin-loaded small-molecule nanoprodrugs enhance anticancer activity in hepatocellular carcinoma J Wang, J Zhuo, Y Tao, S Xu, Z Chen, F Yang, Q Ke, H Xie, S Zheng, ... International Journal of Nanomedicine, 6839-6854, 2020 | 10 | 2020 |
| Delivery of microRNA-33 antagomirs by mesoporous silica nanoparticles to ameliorate lipid metabolic disorders Y Tao, S Xu, J Wang, L Xu, C Zhang, K Chen, Z Lian, J Zhou, H Xie, ... Frontiers in Pharmacology 11, 921, 2020 | 10 | 2020 |
| When immunotherapy meets liver transplantation for hepatocellular carcinoma: a bumpy but promising road Y Gu, S Xu, Z Wang, J Yang, S Zheng, Q Wei, Z Liu, X Xu Chinese Journal of Cancer Research 35 (2), 92, 2023 | 9 | 2023 |
| TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma J Yu, S Ling, J Hong, L Zhang, W Zhou, L Yin, S Xu, Q Que, Y Wu, Q Zhan, ... Journal for Immunotherapy of Cancer 11 (11), 2023 | 4 | 2023 |
| Insights into the history and tendency of liver transplantation for liver cancer: a bibliometric-based visual analysis X He, S Xu, L Tang, S Ling, X Wei, X Xu International Journal of Surgery 110 (1), 406-418, 2024 | 3 | 2024 |
| Gp78 deficiency in hepatocytes alleviates hepatic ischemia-reperfusion injury via suppressing ACSL4-mediated ferroptosis C Li, Y Wu, K Chen, R Chen, S Xu, B Yang, Z Lian, X Wang, K Wang, ... Cell Death & Disease 14 (12), 810, 2023 | 2 | 2023 |
| Ubiquitin‐specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma Q Ye, W Zhou, S Xu, Q Que, Q Zhan, L Zhang, S Zheng, S Ling, X Xu MedComm 4 (6), e439, 2023 | 1 | 2023 |
| Development and Validation of a Novel Nomogram Integrated with Hypoxic and Lactate Metabolic Characteristics for Prognosis Prediction in Hepatocellular Carcinoma X Qiu, L Dong, K Wang, X Zhong, H Xu, S Xu, H Guo, X Wei, W Chen, ... Journal of Hepatocellular Carcinoma, 241-255, 2024 | | 2024 |
